Comparison of the Effectiveness of Magnesium Oxide and Elobixibat on Improving Rectal Sensitivity and Colonic Transit Time in Patients With Chronic Constipation: An Observational Study
Takaomi Kessoku, Yo Ishihara, Kota Takahashi, Thanh Huy Dang, Mayumi Ohira, Mayu Horiuchi, Chiharu Shibata, Ayaka Uchida, Yukiko Toriumi, Noboru Misawa, Hidenori Ohkubo, Kento Imajo, Shunsuke Oyamada, Tomoyuki Iwasaki, Takeo Kurihashi, Noriaki Manabe, Tatsuya Abe, Atsushi NakajimaABSTRACT
Background
We compared the effectiveness of magnesium oxide (MgO) and elobixibat (EXB) in improving defecation desire (DD), rectal sensation, and colonic transit time (CTT) in patients with chronic constipation (CC).
Methods
This was a prospective, observational study conducted in real‐world clinical practice. We included patients with CC who met the Rome IV criteria and underwent colon transit study and rectal sensory tests (
Key Results
Patients in the MgO (n = 30) and EXB (n = 43) groups had comparable demographic characteristics, an average prescription duration of 27 days, and average daily dosages of 1413 and 13 mg, respectively. Patients in the MgO and EXB groups showed different improvement rate of LODD (33% vs. 65%, p < 0.001), absolute changes in FDDV (−0.1 vs. 35 mL, p < 0.0001), and shift rate from STC to NTC (37% vs. 87%, p = 0.003, respectively).
Conclusions and Inferences
EXB demonstrated significantly greater improvements of LODD, rectal sensation, and CTT compared to MgO.